nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2A6—Fluorouracil—urinary bladder cancer	0.201	0.326	CbGbCtD
Dexfenfluramine—CYP2E1—Etoposide—urinary bladder cancer	0.111	0.18	CbGbCtD
Dexfenfluramine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0768	0.124	CbGbCtD
Dexfenfluramine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0692	0.112	CbGbCtD
Dexfenfluramine—CYP1A2—Etoposide—urinary bladder cancer	0.0641	0.104	CbGbCtD
Dexfenfluramine—CYP2C9—Cisplatin—urinary bladder cancer	0.0588	0.0953	CbGbCtD
Dexfenfluramine—CYP2D6—Doxorubicin—urinary bladder cancer	0.036	0.0584	CbGbCtD
Dexfenfluramine—CYP2C19—urine—urinary bladder cancer	0.0143	0.12	CbGeAlD
Dexfenfluramine—CYP1A2—urine—urinary bladder cancer	0.0117	0.0977	CbGeAlD
Dexfenfluramine—CYP2C9—urine—urinary bladder cancer	0.0111	0.0927	CbGeAlD
Dexfenfluramine—CYP2E1—urine—urinary bladder cancer	0.0105	0.0879	CbGeAlD
Dexfenfluramine—CYP2D6—urine—urinary bladder cancer	0.00831	0.0696	CbGeAlD
Dexfenfluramine—CYP2A6—prostate gland—urinary bladder cancer	0.00797	0.0668	CbGeAlD
Dexfenfluramine—CYP2A6—seminal vesicle—urinary bladder cancer	0.00674	0.0565	CbGeAlD
Dexfenfluramine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00434	0.0364	CbGeAlD
Dexfenfluramine—CYP2A6—vagina—urinary bladder cancer	0.00394	0.033	CbGeAlD
Dexfenfluramine—CYP2E1—prostate gland—urinary bladder cancer	0.00377	0.0315	CbGeAlD
Dexfenfluramine—HTR2C—female reproductive system—urinary bladder cancer	0.00356	0.0298	CbGeAlD
Dexfenfluramine—SLC6A4—female reproductive system—urinary bladder cancer	0.00338	0.0283	CbGeAlD
Dexfenfluramine—HTR2B—female reproductive system—urinary bladder cancer	0.00335	0.028	CbGeAlD
Dexfenfluramine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00319	0.0267	CbGeAlD
Dexfenfluramine—HTR2B—vagina—urinary bladder cancer	0.00303	0.0253	CbGeAlD
Dexfenfluramine—CYP1A2—renal system—urinary bladder cancer	0.00285	0.0239	CbGeAlD
Dexfenfluramine—CYP2E1—renal system—urinary bladder cancer	0.00257	0.0215	CbGeAlD
Dexfenfluramine—CYP2C19—vagina—urinary bladder cancer	0.00253	0.0212	CbGeAlD
Dexfenfluramine—CYP2E1—urethra—urinary bladder cancer	0.00252	0.0211	CbGeAlD
Dexfenfluramine—CYP2C9—female reproductive system—urinary bladder cancer	0.00217	0.0182	CbGeAlD
Dexfenfluramine—CYP2E1—female reproductive system—urinary bladder cancer	0.00206	0.0172	CbGeAlD
Dexfenfluramine—CYP2D6—renal system—urinary bladder cancer	0.00203	0.017	CbGeAlD
Dexfenfluramine—HTR2B—lymph node—urinary bladder cancer	0.00196	0.0164	CbGeAlD
Dexfenfluramine—CYP2D6—female reproductive system—urinary bladder cancer	0.00163	0.0136	CbGeAlD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000171	0.000648	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000166	0.000628	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GLI1—urinary bladder cancer	0.000164	0.00062	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000161	0.000612	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HDAC4—urinary bladder cancer	0.000158	0.000597	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000156	0.00059	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000154	0.000583	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000147	0.000557	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000146	0.000553	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000146	0.000553	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TYMP—urinary bladder cancer	0.000145	0.000549	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000143	0.000544	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000143	0.000543	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.000142	0.000536	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.00014	0.000532	CbGpPWpGaD
Dexfenfluramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00014	0.000529	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000138	0.000523	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000137	0.00052	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	0.000134	0.000508	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	0.000134	0.000508	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000133	0.000506	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000133	0.000504	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000133	0.000504	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GLI1—urinary bladder cancer	0.000132	0.0005	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000132	0.0005	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NAT2—urinary bladder cancer	0.000131	0.000497	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000131	0.000496	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.00013	0.000494	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	0.000123	0.000465	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	0.000122	0.000461	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	0.00012	0.000455	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.00012	0.000454	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	0.000115	0.000434	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000114	0.000431	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000114	0.000431	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	0.000113	0.00043	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—RRM2—urinary bladder cancer	0.000113	0.000429	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RBX1—urinary bladder cancer	0.000112	0.000425	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000112	0.000424	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000111	0.00042	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	0.000111	0.000419	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	0.00011	0.000419	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	0.00011	0.000415	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000106	0.000403	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TSC1—urinary bladder cancer	0.000105	0.0004	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	0.000105	0.000397	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ENO2—urinary bladder cancer	0.000105	0.000397	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	0.000104	0.000395	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000104	0.000394	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	0.000104	0.000393	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	0.000103	0.000392	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	0.000102	0.000385	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	0.000102	0.000385	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	0.000101	0.000382	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—JAG1—urinary bladder cancer	0.0001	0.00038	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	9.36e-05	0.000355	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RBX1—urinary bladder cancer	9.05e-05	0.000343	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	8.94e-05	0.000339	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.86e-05	0.000336	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	8.84e-05	0.000335	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	8.84e-05	0.000335	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	8.61e-05	0.000326	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TSC1—urinary bladder cancer	8.51e-05	0.000322	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	8.49e-05	0.000322	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—RHOA—urinary bladder cancer	8.49e-05	0.000322	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	8.45e-05	0.00032	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	8.28e-05	0.000314	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	8.28e-05	0.000314	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—S100B—urinary bladder cancer	8.13e-05	0.000308	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	8.13e-05	0.000308	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—JAG1—urinary bladder cancer	8.1e-05	0.000307	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	8.08e-05	0.000306	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	8.06e-05	0.000305	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	8.03e-05	0.000304	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	7.99e-05	0.000303	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.74e-05	0.000293	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—RHOA—urinary bladder cancer	7.71e-05	0.000292	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.45e-05	0.000282	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	7.35e-05	0.000279	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NCOR1—urinary bladder cancer	7.31e-05	0.000277	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	7.29e-05	0.000276	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2—urinary bladder cancer	7.12e-05	0.00027	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	7.05e-05	0.000267	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.91e-05	0.000262	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	6.9e-05	0.000261	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	6.89e-05	0.000261	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—RHOA—urinary bladder cancer	6.85e-05	0.000259	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—CXCL8—urinary bladder cancer	6.77e-05	0.000256	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	6.68e-05	0.000253	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.61e-05	0.000251	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—S100B—urinary bladder cancer	6.56e-05	0.000249	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	6.55e-05	0.000248	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	6.48e-05	0.000245	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	6.48e-05	0.000245	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2—urinary bladder cancer	6.47e-05	0.000245	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TERT—urinary bladder cancer	6.44e-05	0.000244	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	6.39e-05	0.000242	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	6.39e-05	0.000242	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	6.35e-05	0.000241	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	6.35e-05	0.00024	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	6.29e-05	0.000238	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	6.23e-05	0.000236	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—RHOA—urinary bladder cancer	6.22e-05	0.000236	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	6.2e-05	0.000235	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	6.2e-05	0.000235	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.1e-05	0.000231	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	6.09e-05	0.000231	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—CXCL8—urinary bladder cancer	6.01e-05	0.000228	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—FGFR3—urinary bladder cancer	5.91e-05	0.000224	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NCOR1—urinary bladder cancer	5.9e-05	0.000224	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	5.88e-05	0.000223	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	5.88e-05	0.000223	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	5.83e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	5.83e-05	0.000221	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.79e-05	0.00022	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2—urinary bladder cancer	5.75e-05	0.000218	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ESR1—urinary bladder cancer	5.74e-05	0.000218	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	5.72e-05	0.000217	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	5.7e-05	0.000216	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	5.65e-05	0.000214	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	5.57e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.56e-05	0.000211	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—CXCL8—urinary bladder cancer	5.46e-05	0.000207	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	5.38e-05	0.000204	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—urinary bladder cancer	5.22e-05	0.000198	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TERT—urinary bladder cancer	5.2e-05	0.000197	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	5.18e-05	0.000196	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	5.15e-05	0.000195	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	5.12e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	5.12e-05	0.000194	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CREBBP—urinary bladder cancer	5.03e-05	0.000191	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5e-05	0.000189	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	4.98e-05	0.000189	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	4.98e-05	0.000189	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IGF1—urinary bladder cancer	4.97e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.95e-05	0.000188	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—urinary bladder cancer	4.95e-05	0.000187	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	4.9e-05	0.000186	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	4.83e-05	0.000183	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	4.81e-05	0.000182	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—FGFR3—urinary bladder cancer	4.77e-05	0.000181	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.76e-05	0.00018	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	4.74e-05	0.00018	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	4.7e-05	0.000178	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—KRAS—urinary bladder cancer	4.67e-05	0.000177	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	4.64e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ESR1—urinary bladder cancer	4.63e-05	0.000176	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.56e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RHOA—urinary bladder cancer	4.55e-05	0.000173	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	4.52e-05	0.000171	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	4.46e-05	0.000169	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.36e-05	0.000165	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	4.3e-05	0.000163	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB2—urinary bladder cancer	4.21e-05	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.16e-05	0.000158	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CREBBP—urinary bladder cancer	4.06e-05	0.000154	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	4.01e-05	0.000152	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF1—urinary bladder cancer	4.01e-05	0.000152	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CXCL8—urinary bladder cancer	4e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.99e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—urinary bladder cancer	3.99e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.97e-05	0.000151	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—HRAS—urinary bladder cancer	3.97e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	3.95e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.95e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.95e-05	0.00015	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	3.92e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.89e-05	0.000148	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—urinary bladder cancer	3.82e-05	0.000145	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.79e-05	0.000144	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	3.78e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—KRAS—urinary bladder cancer	3.77e-05	0.000143	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—urinary bladder cancer	3.72e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	3.71e-05	0.000141	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	3.67e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RHOA—urinary bladder cancer	3.67e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	3.67e-05	0.000139	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	3.65e-05	0.000138	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	3.64e-05	0.000138	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	3.63e-05	0.000138	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	3.63e-05	0.000138	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—urinary bladder cancer	3.62e-05	0.000137	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CDKN1A—urinary bladder cancer	3.6e-05	0.000137	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	3.6e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	3.6e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTEN—urinary bladder cancer	3.59e-05	0.000136	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	3.52e-05	0.000133	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	3.49e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	3.48e-05	0.000132	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	3.45e-05	0.000131	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	3.43e-05	0.00013	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	3.41e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	3.4e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.4e-05	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	3.38e-05	0.000128	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	3.35e-05	0.000127	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	3.33e-05	0.000126	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.24e-05	0.000123	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	3.22e-05	0.000122	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	3.21e-05	0.000122	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	3.2e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	3.18e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	3.18e-05	0.000121	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	3.11e-05	0.000118	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	3.08e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	3.08e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	3.08e-05	0.000117	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—EP300—urinary bladder cancer	3.04e-05	0.000115	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	3e-05	0.000114	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	2.99e-05	0.000113	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.95e-05	0.000112	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	2.92e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	2.92e-05	0.000111	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	2.91e-05	0.00011	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	2.9e-05	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.89e-05	0.00011	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.88e-05	0.000109	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.83e-05	0.000107	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	2.77e-05	0.000105	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	2.76e-05	0.000105	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	2.72e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.72e-05	0.000103	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	2.69e-05	0.000102	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	2.6e-05	9.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	2.58e-05	9.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	2.52e-05	9.53e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	2.5e-05	9.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	2.48e-05	9.39e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	2.45e-05	9.3e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	2.41e-05	9.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—EP300—urinary bladder cancer	2.4e-05	9.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	2.36e-05	8.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	2.35e-05	8.89e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	2.23e-05	8.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	2.23e-05	8.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	2.2e-05	8.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	2.12e-05	8.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	2.05e-05	7.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	2.03e-05	7.69e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	1.98e-05	7.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.94e-05	7.36e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	1.89e-05	7.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.85e-05	7.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.79e-05	6.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.77e-05	6.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.73e-05	6.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.7e-05	6.45e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.69e-05	6.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.51e-05	5.73e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.44e-05	5.47e-05	CbGpPWpGaD
